How to Buy Kyntra Bio Stock

Kyntra Bio Inc

Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction.

Kyntra Bio stock last closed at $7.23, down 2.17% from the previous day, and has decreased 10.41% in one year. It has underperformed other stocks in the Biotechnology industry by 0.21 percentage points. Kyntra Bio stock is currently +14.4% from its 52-week low of $6.32, and -42.62% from its 52-week high of $12.60.

As of Jul 17, 2026, there are 4.05M KYNB shares outstanding. The market value of KYNB is $29.27M. In the last 24 hours, 9400 KYNB shares were traded.

How to Buy Kyntra Bio Stock

Wondering how to invest in Kyntra Bio stock? Here's how.

  1. Decide where to buy Kyntra Bio stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Kyntra Bio stock.
  2. Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Fund your investment account: Pick your method of payment and add your info.
  4. Analyze Kyntra Bio stock: The Kyntra Bio ticker symbol is KYNB. Is Kyntra Bio stock a good investment? Should you buy shares of KYNB? How do KYNB's underlying business fundamentals look? Do top analysts think Kyntra Bio is a good buy? Why has KYNB's stock price moved recently? (Hint: Our stock research tools can help you understand if KYNB is a good stock to buy).
  5. Place your KYNB purchase: Decide if you will purchase KYNB shares at the current market price or use a limit order to purchase KYNB shares at a particular price.
  6. Get key alerts regarding your investment in KYNB: Create a watchlist to monitor your investment in Kyntra Bio shares.

Step 1: Decide where to buy Kyntra Bio stock

You need an online brokerage account in order to access the NASDAQ market and buy KYNB shares.

A brokerage account enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

In our opinion, eToro is the best brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've chosen the best brokerage, the next step is to fill out some personal info so you can invest in KYNB today.

How to Create a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to create your new trading account.
  1. Send your details by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have opened your account on the best stock trading app, you can securely and quickly fund your account:

Check out the video below if you need help transferring funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Kyntra Bio stock

After you have figured out the best place to buy Kyntra Bio stock, it's very important to evaluate their stock prior to investing, so you can comprehend the risk as well as the upside.

Kyntra Bio Metrics

KYNB Price
$7.23
1w %
-4.93%
1y %
-10.41%
5y %
-97.89%
P/E
0.18x
P/B
-0.67x
P/S
3.93x
PEG
N/A
Revenue
$7.44M
Earnings
$163.62M
Fore. Rev. Growth
11.46%
Fore. Earn. Growth
N/A
Market Cap
$29.27M
Next Earnings
Aug 10, 2026
Next Dividend
N/A

Fundamentals of Kyntra Bio

WallStreetZen was designed to help average investors perform more accurate fundamental analysis in less time.

You can see all of the due diligence checks on KYNB's stock page.

What is the fair value of KYNB stock?

You can use many financial metrics, analyses, models, and charts to gauge KYNB's true value.

Using relative valuations ratios:

  • KYNB could be undervalued based on its P/E ratio of 0.18x, relative to Biotechnology industry P/E ratio of 20.78x

You can do more valuation analysis on KYNB's stock here.

Is KYNB a healthy company?

Positive Health Checks:

  • KYNB has cash burn of 21402000. It has enough cash and short-term investments to cover this for at least one year.
  • KYNB profit margin has gone up from -143.1% to 2,199.4% in the past year.
  • There are more short-term assets than short-term liabilities on the KYNB balance sheet.
  • KYNB has $87.24M in cash and short term investments. This is enough to cover its annual cash burn of $21.40M.
  • There are more short-term assets than long-term liabilities on the KYNB balance sheet.

Negative Health Checks:

  • Total KYNB debt is still negative.
  • KYNB debt to equity ratio of -2.72 is negative.

Do Wall Street analysts think it's a good time to buy Kyntra Bio stock

Out of 2 Wall Street analysts who give forecasts on KYNB, the consensus analyst rating on KYNB is a Strong Buy

Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Kyntra Bio stock forecast page.

KYNB Technical Indicators

SMA10
7.37
SMA20
7.27
SMA50
7.05
SMA100
7.05
SMA200
8.19
MACD
0.09
MACD Signal
0.12
MACD Histogram
-0.02
RSI
50.19
Stochastic %K
46.59
Stochastic %D
49.44
StochRSI %K
7.76
StochRSI %D
7.69

KYNB Revenue

Last year, KYNB revenue was $7.44M. Over the past five year, KYNB's revenue has grown by -47.71% per year. This was slower than the Biotechnology industry average of 31.06%.

Find out more about KYNB's earnings and revenue performance here.

Who is buying/selling KYNB?

In the past 12 months, insiders at KYNB have bought more shares than they have sold.

David Delucia, Chief Financial Officer of KYNB, was the latest KYNB insider to sell. They sold $348.92 worth of KYNB shares on Jun 6, 2026.

Research more about who owns KYNB shares here.

Does KYNB stock generate passive income?

No, Kyntra Bio doesn't provide an income stream by paying out dividends.

What do other traders have to say about KYNB?

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Place your KYNB purchase

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at an exact price, use a limit order.

Press the Open button and your broker will place the order.

If you want additional assistance investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get key alerts regarding your investment in KYNB

Now that you own some shares in KYNB, you'll want to stay up-to-date on your new shares.

Add KYNB to a watchlist to track the most important metrics related to your KYNB stock.

KYNB Feed

How to Buy Stock in Kyntra Bio

To reiterate, here are the 6 steps you need to take to buy Kyntra Bio stock right now:

  1. Decide where to buy Kyntra Bio stock
  2. Open your brokerage account
  3. Fund your investment account
  4. Analyze Kyntra Bio stock
  5. Place your KYNB purchase
  6. Get key alerts regarding your investment in KYNB

If you are looking for a brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to watch your new investment in Kyntra Bio, click the button below.

NASDAQ: KYNB
$7.23-0.16 (-2.17%)
Updated Jul 17, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: KYNB
$7.23-0.16 (-2.17%)
Updated Jul 17, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Kyntra Bio share?

As of Jul 17, 2026, it costs $7.23 to buy one share of Kyntra Bio stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.415 shares of KYNB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Kyntra Bio stock?

According to 2 Wall Street analysts who monitor Kyntra Bio, their consensus recommendation is to buy Kyntra Bio stock.

What is the best way to buy Kyntra Bio stock?

One way to place an order for Kyntra Bio stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.